J.P. Morgan raises Astera Labs price target to $280 from $205 and keeps Overweight

J.P. Morgan kept its Overweight rating on Astera Labs and raised its price target to $280 from $205 after the first-quarter report. Other firms covering the stock were also lifting targets in the same period, with Jefferies at $270 (Buy), Needham at $260 (Buy) and Morgan Stanley at $240 (Overweight). The revisions followed first-quarter revenue of $308.4 million and higher second-quarter guidance.

• J.P. Morgan: Overweight, target raised to $280 from $205
• Jefferies: $270, Buy
• Needham: $260, Buy
• Morgan Stanley: $240, Overweight